Most Popular Articles

Sexual activity and function assessment in middle-aged Chinese women using the female sexual function index

Zhang, Caiyun; Cui, Liping; Zhang, Lizhi; More

Menopause. 24(6):669-676, June 2017.

Open

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. 26(10):1213-1227, October 2019.

Open

Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy

Chang, Heidi; Kamara, Daniella; Bresee, Catherine; More

Menopause. 28(4):354-359, April 2021.

Physical performance in relation to menopause status and physical activity

Bondarev, Dmitriy; Laakkonen, Eija K.; Finni, Taija; More

Menopause. 25(12):1432-1441, December 2018.

Open
SDC

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. 26(9):1071-1084, September 2019.

Open

The role of physical activity in the link between menopausal status and mental well-being

Bondarev, Dmitriy; Sipilä, Sarianna; Finni, Taija; More

Menopause. 27(4):398-409, April 2020.

Open
SDC

Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial

Pauwaert, Kim; Goessaert, An-Sofie; Ghijselings, Lynn; More

Menopause. 28(5):502-510, May 2021.

Free
SDC

The MATE survey: men's perceptions and attitudes towards menopause and their role in partners’ menopausal transition

Parish, Sharon J.; Faubion, Stephanie S.; Weinberg, Marc; More

Menopause. 26(10):1110-1116, October 2019.

Open
SDC

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

Open

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Constantine, Ginger D.; Graham, Shelli; Lapane, Kate; More

Menopause. 26(7):800-807, July 2019.

Open
SDC

Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea

Lee, Jae Hoon; Kim, Yong Chan; Cho, Si Hyun; More

Menopause. 27(12):1376-1381, December 2020.

Open
SDC

Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging

Price, Madison A.; Alvarado, Beatriz E.; Rosendaal, Nicole T.A.; More

Menopause. 28(5):484-490, May 2021.

Open
SDC

Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis

Harder, Helena; Starkings, Rachel M.L.; Fallowfield, Lesley J.; More

Menopause. 26(10):1100-1009, October 2019.

Open
SDC

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

Portman, David J.; Kaunitz, Andrew M.; Kazempour, Kazem; More

Menopause. 21(10):1082-1090, October 2014.

Open
SDC

What providers need to know about progestogens in hormone therapy

Liu, James H.

Menopause. 28(3):325-326, March 2021.

Free

The many menopauses: searching the cognitive research literature for menopause types

Edwards, Hannaford; Duchesne, Annie; Au, April S.; More

Menopause. 26(1):45-65, January 2019.

Open

Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall

Ripperda, Christopher M.; Maldonado, Pedro Antonio; Acevedo, Jesus F.; More

Menopause. 24(7):838-849, July 2017.

Open
SDC

Cognitive changes during the menopausal transition: a longitudinal study in women with and without HIV

Maki, Pauline M.; Springer, Gayle; Anastos, Kathryn; More

Menopause. 28(4):360-368, April 2021.

Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy

Wang, Yiwei; Hernandez, Gerson; Mack, Wendy J.; More

Menopause. 27(1):57-65, January 2020.

Open
SDC

A prospective study of the relationships between change in body composition and cardiovascular risk factors across the menopause

Dehghan, Aaron; Vasan, Senthil K.; Fielding, Barbara A.; More

Menopause. 28(4):400-406, April 2021.

Open
SDC

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study

Coelingh Bennink, Herjan J.T.; Verhoeven, Carole; Zimmerman, Yvette; More

Menopause. 24(6):677-685, June 2017.

Open

Tissue selective estrogen complex (TSEC): a review

Pickar, James H.; Boucher, Matthieu; Morgenstern, Diana

Menopause. 25(9):1033-1045, September 2018.

Open

Brain functional changes in perimenopausal women: an amplitude of low-frequency fluctuation study

Liu, Ningning; Zhang, Yue; Liu, Shuang; More

Menopause. 28(4):384-390, April 2021.

Open

The 2017 hormone therapy position statement of The North American Menopause Society

The North American Menopause Society

Menopause. 24(7):728-753, July 2017.

Take the CME Test
Buy

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

Hirschberg, Angelica Lindén; Sánchez-Rovira, Pedro; Presa-Lorite, Jesús; More

Menopause. 27(5):526-534, May 2020.

Open
SDC

Association between osteoporosis and menopause in relation to SOX6 rs297325 variant in Taiwanese women

Hsu, Tzu-Liang; Tantoh, Disline Manli; Chou, Ying-Hsiang; More

Menopause. 27(8):887-892, August 2020.

Open

Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial

Taguchi, Akira; Shiraki, Masataka; Tanaka, Satoshi; More

Menopause. 26(11):1277-1283, November 2019.

Open
SDC

Dairy intake is not associated with improvements in bone mineral density or risk of fractures across the menopause transition: data from the Study of Women's Health Across the Nation

Wallace, Taylor C.; Jun, Shinyoung; Zou, Peishan; More

Menopause. 27(8):879-886, August 2020.

Open
SDC

High-density lipoprotein cholesterol and arterial calcification in midlife women: the contribution of estradiol and C-reactive protein

Swabe, Gretchen; Matthews, Karen; Brooks, Maria; More

Menopause. 28(3):237-246, March 2021.

Free
SDC

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

Open

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Archer, David F.; Goldstein, Steven R.; Simon, James A.; More

Menopause. 26(6):611-621, June 2019.

Open
SDC

Systemic estradiol levels with low-dose vaginal estrogens

Santen, Richard J.; Mirkin, Sebastian; Bernick, Brian; More

Menopause. 27(3):361-370, March 2020.

Open

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

Open
SDC

The genitourinary syndrome of menopause

Phillips, Nancy A.; Bachmann, Gloria A.

Menopause. 28(5):579-588, May 2021.

What's in a name: are menopausal “hot flashes” a symptom of menopause or a manifestation of neurovascular dysregulation?

Miller, Virginia M.; Kling, Juliana M.; Files, Julia A.; More

Menopause. 25(6):700-703, June 2018.

Open

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Constantine, Ginger D.; Archer, David F.; Graham, Shelli; More

Menopause. 23(10):1075-1082, October 2016.

Open
SDC

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Free

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial

Trower, Mike; Anderson, Richard A.; Ballantyne, Elizabeth; More

Menopause. 27(5):498-505, May 2020.

Open

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

Simon, James A.; Portman, David J.; Kaunitz, Andrew M.; More

Menopause. 20(10):1027-1035, October 2013.

Free

Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets

Derzko, Christine M.; Röhrich, Sebastian; Panay, Nick

Menopause. 28(2):113-118, February 2021.

Effects of stretching on menopausal and depressive symptoms in middle-aged women: a randomized controlled trial

Kai, Yuko; Nagamatsu, Toshiya; Kitabatake, Yoshinori; More

Menopause. 23(8):827-832, August 2016.

Open

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Maki, Pauline M.; Kornstein, Susan G.; Joffe, Hadine; More

Menopause. 25(10):1069-1085, October 2018.

Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy

Pickar, James H.; Bon, Charles; Amadio, Julia M.; More

Menopause. 22(12):1308-1316, December 2015.

Open

Age at natural menopause and physical functioning in postmenopausal women: the Canadian Longitudinal Study on Aging

Velez, Maria P.; Alvarado, Beatriz E.; Rosendaal, Nicole; More

Menopause. 26(9):958-965, September 2019.

Open
Erratum

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

Pinkerton, JoAnn V.; Joffe, Hadine; Kazempour, Kazem; More

Menopause. 22(1):50-58, January 2015.

Open

Genitourinary syndrome of menopause: the unmet need

Spadt, Susan Kellogg; Larkin, Lisa C.

Menopause. 28(4):444-446, April 2021.

Menopause, the gut microbiome, and weight gain: correlation or causation?

Becker, Sarah L.; Manson, JoAnn E.

Menopause. 28(3):327-331, March 2021.

WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history

Kingsberg, Sheryl A.; Larkin, Lisa; Krychman, Michael; More

Menopause. 26(2):124-131, February 2019.

Open

Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies

Stanczyk, Frank Z.; Niu, Chunying; Azen, Colleen; More

Menopause. 26(9):966-971, September 2019.

Open
SDC

Maintaining cognitive function in surgically menopausal women: the importance of estrogen

Kaunitz, Andrew M.; Kapoor, Ekta; Faubion, Stephanie

Menopause. 28(4):349-351, April 2021.

Combined exercise reduces arterial stiffness, blood pressure, and blood markers for cardiovascular risk in postmenopausal women with hypertension

Son, Won-Mok; Sung, Ki-Dong; Cho, Jae-Min; More

Menopause. 24(3):262-268, March 2017.

The effects of mindfulness and relaxation training for insomnia (MRTI) on postmenopausal women: a pilot study

Garcia, Marcelo C.; Kozasa, Elisa H.; Tufik, Sergio; More

Menopause. 25(9):992-1003, September 2018.

Timing and type of menopause and risk of cardiovascular disease

Hickey, Martha; Mishra, Gita D.

Menopause. 28(5):477-479, May 2021.

Compounded bioidentical hormone therapy: new recommendations from the 2020 National Academies of Sciences, Engineering, and Medicine

Stuenkel, Cynthia A.

Menopause. 28(5):576-578, May 2021.

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

Open
SDC

Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications

Glaser, Rebecca L.; York, Anne E.; Dimitrakakis, Constantine

Menopause. 24(7):859-864, July 2017.

Open

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms

Simon, James A.; Kaunitz, Andrew M.; Kroll, Robin; More

Menopause. 26(5):506-512, May 2019.

Open

Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis

Atsma, Femke; Bartelink, Marie-Louise E. L.; Grobbee, Diederick E.; More

Menopause. 13(2):265-279, March-April 2006.

Improvement in sleep outcomes with a 17β-estradiol–progesterone oral capsule (TX-001HR) for postmenopausal women

Kagan, Risa; Constantine, Ginger; Kaunitz, Andrew M.; More

Menopause. 26(6):622-628, June 2019.

Open

Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial

Green, Sheryl M.; Donegan, Eleanor; Frey, Benicio N.; More

Menopause. 26(9):972-980, September 2019.

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

Kroll, Robin; Archer, David F.; Lin, Yuhua; More

Menopause. 25(2):133-138, February 2018.

Open

Protocol for development of a core outcome set for menopausal symptoms (COMMA)

Kim, Bobae V.; Iliodromiti, Stamatina; Christmas, Monica; More

Menopause. 27(12):1371-1375, December 2020.

Open
SDC

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial

Black, Denise R.; Minkin, Mary Jane; Graham, Shelli; More

Menopause. 28(1):32-39, January 2021.

Open

The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial

Nudy, Matthew; Jiang, Xuezhi; Aragaki, Aaron K.; More

Menopause. 27(11):1265-1273, November 2020.

The Women's Health Initiative trials of menopausal hormone therapy: lessons learned

Manson, JoAnn E.; Bassuk, Shari S.; Kaunitz, Andrew M.; More

Menopause. 27(8):918-928, August 2020.

Efficacy and safety of endocrine therapy for breast-cancer prevention in high-risk premenopausal or postmenopausal women: a Bayesian network meta-analysis of nine randomized controlled trials

Sun, Rong; Chu, Yan; Gao, Yan; More

Menopause. 28(5):589-600, May 2021.

Transitioning to the menopausal transition: a scoping review of research on the late reproductive stage in reproductive aging

Woods, Nancy Fugate; Mitchell, Ellen Sullivan; Coslov, Nina; More

Menopause. 28(4):447-466, April 2021.

A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial

Paraiso, Marie Fidela R.; Ferrando, Cecile A.; Sokol, Eric R.; More

Menopause. 27(1):50-56, January 2020.

lncRNA HEIH accelerates cell proliferation and inhibits cell senescence by targeting miR-3619-5p/CTTNBP2 axis in ovarian cancer: Erratum

Menopause. 28(5):601, May 2021.

Free

Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model

Katri, Anna; Reker, Ditte; Karsdal, Morten A.; More

Menopause. 28(4):423-430, April 2021.

Open

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative

Chlebowski, Rowan T.; Mortimer, Joanne E.; Crandall, Carolyn J.; More

Menopause. 26(6):578-587, June 2019.

The association between hormone therapy and sarcopenia in postmenopausal women: the Korea National Health and Nutrition Examination Survey, 2008-2011

Kim, Sung-Woo; Kim, Rebecca

Menopause. 27(5):506-511, May 2020.

Open

Lifetime estrogen exposure and cognition in late life: the Cache County Study

Matyi, Joshua M.; Rattinger, Gail B.; Schwartz, Sarah; More

Menopause. 26(12):1366-1374, December 2019.

Effects of menopause on sleep quality and sleep disorders: Canadian Longitudinal Study on Aging

Zolfaghari, Sheida; Yao, Chun; Thompson, Cynthia; More

Menopause. 27(3):295-304, March 2020.

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society

Menopause. 22(11):1155-1174, November 2015.

Take the CME Test
Buy

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety

Gaspard, Ulysse; Taziaux, Mélanie; Mawet, Marie; More

Menopause. 27(8):848-857, August 2020.

Open
SDC

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Open

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Glazer, Clara; More

Menopause. 22(4):384-390, April 2015.

Open
SDC

Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia

Constantine, Ginger; Millheiser, Leah S.; Kaunitz, Andrew M.; More

Menopause. 26(11):1259-1264, November 2019.

Open

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause. 25(11):1362-1387, November 2018.

#Menopause on Instagram: a mixed-methods study

Arseneau, Morgan E.; Backonja, Uba; Litchman, Michelle L.; More

Menopause. 28(4):391-399, April 2021.

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society

Menopause: The Journal of The North American Menopause Society. 20(9):888-902, September 2013.

Hypertension in menopausal women: the effect and role of estrogen

Srivaratharajah, Kajenny; Abramson, Beth L.

Menopause. 26(4):428-430, April 2019.

Menopause and exercise

Grindler, Natalia M.; Santoro, Nanette F.

Menopause. 22(12):1351-1358, December 2015.

Vaginal pessary treatment in women with symptomatic pelvic organ prolapse: a long-term prospective study

Ma, Congcong; Zhou, Ying; Kang, Jia; More

Menopause. 28(5):538-545, May 2021.

Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women

Kim, Min Kyung; Ahn, Chul Woo; Nam, Ji Sun; More

Menopause. 22(12):1323-1327, December 2015.

Open

The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society

Menopause. 27(9):976-992, September 2020.

Take the CME Test
Buy

Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis

Moslehi, Nazanin; Shab-Bidar, Sakineh; Ramezani Tehrani, Fahimeh; More

Menopause. 25(9):1046-1055, September 2018.

A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause

Biehl, Colton; Plotsker, Olivia; Mirkin, Sebastian

Menopause. 26(4):431-453, April 2019.

Yoga decreases insomnia in postmenopausal women: a randomized clinical trial

Afonso, Rui Ferreira; Hachul, Helena; Kozasa, Elisa Harumi; More

Menopause: The Journal of The North American Menopause Society. 19(2):186-193, February 2012.

Age at natural menopause and its associated factors in Canada: cross-sectional analyses from the Canadian Longitudinal Study on Aging

Costanian, Christy; McCague, Hugh; Tamim, Hala

Menopause. 25(3):265-272, March 2018.

SLCO1B1 genetic variation and hormone therapy in menopausal women

Moyer, Ann M.; de Andrade, Mariza; Faubion, Stephanie S.; More

Menopause. 25(8):877-882, August 2018.

Open

Femtech and midlife women's health: good, bad, or ugly?

Faubion, Stephanie S.

Menopause. 28(4):347-348, April 2021.

Primary ovarian insufficiency associated with autosomal abnormalities: from chromosome to genome-wide and beyond

Vichinsartvichai, Patsama

Menopause. 23(7):806-815, July 2016.

The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society

Menopause. 12(5):497-511, September-October 2005.

Depression, anxiety, and fear of death in postmenopausal women

Ozdemir, Kevser; Sahin, Sevil; Guler, Dondu Sevimli; More

Menopause. 27(9):1030-1036, September 2020.

Twelve weeks of resistance band exercise training improves age-associated hormonal decline, blood pressure, and body composition in postmenopausal women with stage 1 hypertension: a randomized clinical trial

Son, Won-Mok; Pekas, Elizabeth J.; Park, Song-Young

Menopause. 27(2):199-207, February 2020.

Association between hysterectomy and depression: a longitudinal follow-up study using a national sample cohort

Choi, Hyo Geun; Rhim, Chae Chun; Yoon, Ji Young; More

Menopause. 27(5):543-549, May 2020.

Can walking exercise programs improve health for women in menopause transition and postmenopausal? Findings from a scoping review

Sydora, Beate C.; Turner, Cailey; Malley, Alexandra; More

Menopause. 27(8):952-963, August 2020.

Login

Register for a free account

In Brief:

In Brief:

In Brief: